Fig. 2From: Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysisSummary of risk of bias assessment A). Risk of bias assessment: overall risk of bias for all included trials. B). Risk of bias summary: overall risk of bias for all included trialsBack to article page